Sex Differences in Cardiovascular Prevention in Type 2: Diabetes in a Real-World Practice Database

A. RAMIREZ-MORROS, J. FRANCH-NADAL, J. REAL, M. GRATACOS and D. MAURICIO
Journal of Clinical Medicine. 2022 Apr 1; . doi:10.3390/jcm11082196; PMID:35456292

• Any: 01/04/2022
• FI: 3.9
• Article

Mortality trends in type 1 diabetes: a multicountry analysis of six population-based cohorts

P. RUIZ, L. CHEN, J. MORTON, A. SALIM, B. CARSTENSEN, E. GREGG, M. PAVKOV, M. MATA-CASES, D. MAURICIO, G. NICHOLS, Santa Pildava, S. READ, S. WILD, J. SHAW and D. MAGLIANO
Diabetologia. 2022 Jun 1; . doi:10.1007/s00125-022-05659-9; PMID:35314870

• Any: 01/06/2022
• FI: 8.2
• Article

The GenoDiabMar Registry: A Collaborative Research Platform of Type 2 Diabetes Patients

A. SIERRA, S. OTERO, E. RODRIGUEZ, A. FAURA, M. VERA, M. RIERA, V. PALAU, X. DURAN, A. COSTA-GARRIDO, L. SANS, E. MARQUEZ, V. POPOSKI, J. FRANCH-NADAL, X. MUNDET, A. OLIVERAS, M. CRESPO, J. PASCUAL and C. BARRIOS
Journal of Clinical Medicine. 2022 Mar 1; . doi:10.3390/jcm11051431; PMID:35268522

• Any: 01/03/2022
• FI: 3.9
• Article

Half of patients with type 2 diabetes mellitus are at very high cardiovascular risk according to the ESC/EASD: data from a large Mediterranean population

A. CEBRIAN-CUENCA, M. MATA-CASES, J. FRANCH-NADAL, D. MAURICIO, D. OROZCO-BELTRAN and L. CONSUEGRA-SANCHEZ
European Journal of Preventive Cardiology. 2022 Feb 9; . doi:10.1093/eurjpc/zwaa073; PMID:33733654

• Any: 09/02/2022
• FI: 8.3
• Article

Compliance with the DPP-4 inhibitors dose adjustment recommendations based onrenal function in a population database

J. FRANCH-NADAL, J. REAL, M. MATA-CASES, E. ORTEGA, J. VALLES, B. VLACHO and D. MAURICIO
Endocrinologia Diabetes y Nutricion. 2022 Feb 1; . doi:10.1016/j.endinu.2021.01.013; PMID:34088634

• Any: 01/02/2022
• FI: 1.9
• Article